SEI INVESTMENTS CO - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 63 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2023$98,227
-4.3%
100,0000.0%0.00%
Q1 2023$102,598
-3.3%
100,0000.0%0.00%
Q4 2022$106,130
+7.2%
100,0000.0%0.00%
Q3 2022$99,0000.0%100,0000.0%0.00%
Q2 2022$99,000
-1.0%
100,0000.0%0.00%
Q1 2022$100,000
-67.9%
100,000
-66.4%
0.00%
-100.0%
Q4 2021$312,000
-40.0%
298,000
-41.3%
0.00%0.0%
Q3 2021$520,000
-18.2%
508,000
-17.3%
0.00%0.0%
Q2 2021$636,000
-31.4%
614,000
-33.0%
0.00%
-50.0%
Q1 2021$927,000
+33.6%
916,000
+41.6%
0.00%0.0%
Q4 2020$694,000
+46.7%
647,000
+43.5%
0.00%
+100.0%
Q3 2020$473,000
+15.9%
451,000
+35.0%
0.00%0.0%
Q2 2020$408,000
+16.6%
334,0000.0%0.00%0.0%
Q1 2020$350,000
-34.5%
334,000
-33.9%
0.00%
-50.0%
Q4 2019$534,000
+7.7%
505,0000.0%0.00%
+100.0%
Q3 2019$496,000
-5.3%
505,0000.0%0.00%
-50.0%
Q2 2019$524,000
+1.4%
505,0000.0%0.00%0.0%
Q1 2019$517,000505,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
Wellesley Asset Management 53,670$57,726,0003.34%
SHENKMAN CAPITAL MANAGEMENT INC 26,959,000$29,149,0003.04%
ADVENT CAPITAL MANAGEMENT /DE/ 84,134,000$90,539,0001.93%
Cheyne Capital Management (UK) LLP 3,220,000$3,452,0001.75%
PFM Health Sciences, LP 40,300,000$43,210,0001.52%
Sonora Investment Management, LLC 6,370,000$6,807,0000.56%
MACKAY SHIELDS LLC 66,018,000$70,980,0000.49%
ZAZOVE ASSOCIATES LLC 1,500,000$1,608,0000.20%
IRON Financial LLC 275,000$295,0000.15%
PALISADE CAPITAL MANAGEMENT, LP 3,000,000$3,216,0000.08%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders